Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-Negative Bloodstream Isolates
This study is currently recruiting participants.
Verified by University of Pittsburgh, December 2008
Sponsors and Collaborators: University of Pittsburgh
Merck
Information provided by: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00394784
  Purpose

This research is important because it allows for the determination of resistance rates to antibiotics that may not be frequently tested by the clinical microbiology laboratory at University of Pittsburgh Medical Center (UPMC)-Presbyterian. It also will provide antibiotic minimum inhibitory concentrations (MICs) for these pathogens which may help in identifying the best empiric antibiotic option for gram-negative blood stream infections based on known pharmacodynamic parameters.


Condition
Gram-Negative Bacterial Infections

MedlinePlus related topics: Antibiotics Bacterial Infections
U.S. FDA Resources
Study Type: Observational
Study Design: Retrospective
Official Title: Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-Negative Bloodstream Isolates

Further study details as provided by University of Pittsburgh:

Biospecimen Retention:   Samples Without DNA

Biospecimen Description:

No genetic testing will be performed on any of the samples being obtained. The biologic samples will be under the control of the principal investigator of this research project. To protect confidentiality, all personal identifiers (i.e., name, social security number, and birth date) will be removed (de-identified) and replaced with a specific code number. The information linking these code numbers to the corresponding subjects' identities will be kept in a separate, secure location. The investigators on this study will keep the samples indefinitely. If a subject withdraws and provides the request in writing, samples collected and not already processed will be destroyed. All samples will be kept in the investigator's laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.


Estimated Enrollment: 100
Study Start Date: December 2006
Estimated Study Completion Date: December 2012
Detailed Description:

Bacterial cultures will be ordered in the normal clinical course of the management of patients in the liver transplant ICU by the medical team. These cultures are then processed by the clinical Microbiology laboratory in the normal manner. If these cultures grow a Gram-negative bacteria, they are eligible for this study. Typically the clinical Microbiology laboratory saves these bacteria for a period of time after the final microbiology report. At this time, unless asked otherwise, the bacteria will be placed in biohazardous waste containers for proper disposal. If these cultures have grown a Gram-negative bacteria, they are eligible for this study, and will not be disposed of but will be given to the investigators without identifiers for this study. The antibiotic susceptibility of these organisms will be tested by the investigators in a separate research laboratory. Mechanisms of antibiotic resistance may also be assessed.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

positive gram negative bacteria isolates

Criteria

Inclusion Criteria:

  • Patients with positive gram-negative bacteria

Exclusion Criteria:

  • Less than 18 years of age
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00394784

Contacts
Contact: Brian Potoski, PharmD 412-648-6401 potoskiba@upmc.edu
Contact: Diana Lynn Pakstis, RN, BSN 412-648-6553 pakstisdl@dom.pitt.edu

Locations
United States, Pennsylvania
University of Pittsburgh Medical Center Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Brian Potoski, PharmD     412-648-6401     potoskiba@upmc.edu    
Contact: Diana Lynn Pakstis, RN, BSN     412-648-6553     pakstisdl@dom.pitt.edu    
Sub-Investigator: David L Paterson, MD            
Principal Investigator: Brian Potoski, PharmD            
Sponsors and Collaborators
University of Pittsburgh
Merck
Investigators
Principal Investigator: Brian Potoski, PharmD University of Pittsburgh
  More Information

Responsible Party: UPMC ( Brian Potoski, Pharm D )
Study ID Numbers: IRB#0608120
Study First Received: October 30, 2006
Last Updated: December 16, 2008
ClinicalTrials.gov Identifier: NCT00394784  
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pittsburgh:
gram negative bacteria
culture
infection

Study placed in the following topic categories:
Bacterial Infections
Gram-Negative Bacterial Infections

Additional relevant MeSH terms:
Infection

ClinicalTrials.gov processed this record on January 16, 2009